Filing Details

Accession Number:
0001493152-17-012235
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-31 20:05:21
Reporting Period:
2017-10-30
Accepted Time:
2017-10-31 20:05:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
764195 Vbi Vaccines Inc VBIV Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1592969 Sam Chawla C/O Vbi Vaccines Inc., 222 Third
Street, Ste 2241
Cambridge, MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Per Share Acquisiton 2017-10-30 3,100,000 $3.05 9,345,725 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares, No Par Value Per Share 25,000 Direct
Footnotes
  1. These shares are held of record by Perceptive Life Sciences Master Fund Ltd.. As a Portfolio Manager of Perceptive Advisors LLC, a related entity to Perceptive Life Sciences Master Fund Ltd., Mr. Chawla may be deemed to have investment control over any securities owned of record by Perceptive Life Sciences Master Fund Ltd. Mr. Chawla disclaims for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Chawla is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.